That's Derm Good!

What happens when biomedical engineering, personal experience, and artificial intelligence come together to solve some of dermatology's biggest challenges?In this episode of That's Derm Good!, Janelle Ball sits down with Dr. Tiffany St. Bernard, founder and CEO of SOCAi Labs, to discuss how technology is transforming the future of skin and hair health. Drawing from her background in biomedical engineering and her passion for improving healthcare outcomes, Dr. St. Bernard shares the inspiration behind SOCAi Labs and how her team is developing AI-powered tools designed to support both patients and clinicians.The conversation explores the growing role of artificial intelligence in dermatology, particularly for patients with skin of color and those experiencing hair loss. Dr. St. Bernard explains how AI can help improve early detection, monitor disease progression, and provide patients with greater confidence and peace of mind throughout their healthcare journey.Janelle and Dr. St. Bernard also discuss the challenges of building technology in healthcare, why clinician involvement is critical to responsible AI development, and how innovation can help create more equitable dermatologic care. Throughout the episode, Dr. St. Bernard emphasizes that AI should enhance—not replace—the expertise of healthcare professionals, reminding listeners that physicians play an essential role in validating and interpreting AI-driven insights.Whether you're a healthcare professional, technology enthusiast, patient advocate, or simply curious about the future of medicine, this episode offers an inspiring look at how innovation is reshaping dermatology and expanding access to better care.DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatment. That’s Derm Good! is proudly part of Authorized Health—bringing you expert-driven conversations at the intersection of dermatology, access, and innovation

With a background in healthcare investment banking and years of hands-on experience guiding independent physician groups through mergers, acquisitions, and strategic partnerships, Michael Kroin, CEO and Managing Partner of Physician Growth Partners, knows that selling a medical practice isn’t just a financial decision. In this episode of That’s Derm Good!, Michael joins Janelle to unpack what private equity looks like for dermatologists and aesthetic practice owners today. DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatment.Michael Kroin offers clear, no-fluff insight into a landscape that’s often confusing or intimidating. He explains why private equity has become a hot topic in dermatology, what physicians should look for in a partner, and how to avoid common pitfalls. Throughout the conversation, Michael emphasizes a founder-first approach; one that protects the identity of the practice, respects the team, and prioritizes long-term sustainability over short-term gains. He also addresses the role of younger physicians in succession planning, the evolution of aesthetics-focused partnerships, and what the current market tells us about timing and opportunity.SPONSOR: Sanofi and Regeneron invite you to learn more about DUPIXENT (dupilumab) at www.DupixentHCP.com. No Wonder it’s Possible.This episode also explores what practice owners can do before they’re ready to sell, whether that means organizing their finances, clarifying long-term goals, or identifying potential gaps in operations or leadership. Michael shares what makes a practice attractive to buyers and how owners can prepare years in advance to keep their options open and their values intact.This episode is produced by Skip The Boring Stuff, a podcast strategy company for business owners and creatives.

Outcomes improve when practitioners work together, learn from one another, and operate within well-structured medical teams. In this insightful episode, Janelle Ball sits down with Tracey Mancuso, founder of The Derma Room, for a forward-thinking conversation on how aesthetic medicine is evolving and what practitioners and patients need to know to advance the industry safely and ethically, beyond the buttonology of device use.She underscores the importance of active medical directors who are engaged in daily practice, not just on paper, especially as energy-based devices and advanced technologies become more widely used.DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatment.Tracey Mancuso shares how the field of aesthetics has shifted from a narrow focus on beautification to a more holistic, patient-centered emphasis on long-term skin health. Rather than chasing trends or quick fixes, today’s most effective practices prioritize understanding the skin, treating it responsibly, and supporting patients with thoughtful, individualized care.Education emerges as a cornerstone of safe and effective aesthetic medicine. Tracey advocates for accessible, high-quality education for practitioners and patients. A deeper understanding of energy-based treatments, including lasers, is critical to ensuring safety, managing risk, and achieving optimal results. Misconceptions about laser treatments, particularly the belief that they are “one-size-fits-all,” can lead to poor outcomes when providers lack proper training or fail to account for different skin types.ADVERTISER: A message from Sun Pharmaceuticals: For patients with locally advanced basal cell carcinoma who are not candidates for further surgery or radiation, hedgehog pathway inhibitors offer a targeted systemic approach. Staying current on these therapies can help you expand options for appropriate patients.Looking ahead, Tracey shares her perspective on the future of aesthetic medicine, pointing to regenerative practices, continued innovation, and the need for more affordable, accessible education across the industry. Her vision focuses on raising standards, improving safety, and ensuring practitioners and patients are empowered with the knowledge they need.This episode is produced by Skip The Boring Stuff, a podcast strategy company for business owners and creatives.

Dr. Naiem Issa, a board-certified dermatologist and the Medical Director of Research & Academics at Forefront Dermatology, joins Janelle on That’s Derm Good! to explore a major breakthrough in CSU (chronic spontaneous urticaria) care. The FDA’s approval of Rhapsido® (remibrutinib) introduces a targeted BTK inhibitor that offers rapid, meaningful relief for patients who have long struggled with limited treatment options.Dr. Issa’s path into dermatology is anything but traditional. With both an MD and a PhD from Georgetown University, he conducted early work in computational drug discovery that led to the identification of new uses for existing medications. This breakthrough shaped his scientific career. After completing residency and fellowship training, he combined academic research with clinical dermatology, now seeing complex immunology and CSU patients across multiple states while leading clinical trials for new therapies.DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatment.In this episode, Dr. Naiem Issa explains why CSU is so often misunderstood, including why allergy panels are usually negative, why patients bounce between specialists, and why many mistakenly think their condition is triggered by food or environmental exposures. More importantly, he explains how BTK inhibitors target the mast cell “control center,” helping stop hives, swelling, and itch, regardless of whether the patient has an autoimmune or autoallergic variant of CSU.ADVERTISER: A message from Sun Pharmaceuticals: For patients with locally advanced basal cell carcinoma who are not candidates for further surgery or radiation, hedgehog pathway inhibitors offer a targeted systemic approach. Staying current on these therapies can help you expand options for appropriate patients.This conversation blends science, compassion, and practical insight, offering clarity to clinicians, coordinators, and patients navigating a condition that has long lacked effective options.This episode is produced by Skip The Boring Stuff, a podcast strategy company for business owners and creatives.

Dr. Erica Ramos, dermatology PA, CEO of Raven Innovations, and founder of Restore Scalp, joins Janelle on That’s Derm Good! to share the story behind the first and only medicated dry shampoo of its kind.Dr. Ramos’s journey into dermatology began in combat boots. After serving as a medic in the military, she went on to complete PA training through the Guard and Reserve before working across family practice, emergency medicine, and rheumatology. Her move into dermatology was a long time coming, and once she arrived, she quickly saw a recurring problem: countless patients struggling with scalp concerns while relying on dry shampoos that often made things worse.DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatmentOver time, Dr. Erica Ramos noticed herself repeating the same message; many over-the-counter products could help with conditions like seborrheic dermatitis or psoriasis, but only if patients used them correctly. She realized there was a gap in the market for a product that was easy to use, rooted in science, and safe for everyday scalp health. This sparked the idea for Restore Scalp, a medicated powder dry shampoo formulated with salicylic acid and designed to exfoliate, clarify, and support the scalp without fragrance, aerosols, or heavy residues.In this episode, Dr. Ramos walks listeners through the years-long process of researching ingredients, navigating FDA monograph requirements, finding trusted chemists and consultants, and developing a formula gentle enough for sensitive skin but powerful enough to address real scalp issues. She also talks about the unexpected hurdles – self-doubt, confidentiality fears, manufacturing challenges – and the supportive network that helped bring the product to life.ADVERTISER: A message from Sun Pharmaceuticals: For patients with locally advanced basal cell carcinoma who are not candidates for further surgery or radiation, hedgehog pathway inhibitors offer a targeted systemic approach. Staying current on these therapies can help you expand options for appropriate patients.It’s an inspiring episode for innovators, clinicians, and anyone curious about what truly goes into developing a product that earns dermatology’s trust.This episode is produced by Skip The Boring Stuff, a podcast strategy company for business owners and creatives.